Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359720180360010019
Journal of the Korean Neurological Association
2018 Volume.36 No. 1 p.19 ~ p.21
Steroid Non-responsive Hashimoto¡¯s Encephalopathy Improved by Rituximab
Jang Seong-Hwa

Moon Hye-Jin
Cho Yong-Won
Abstract
Hashimoto¡¯s encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are refractory to corticosteroids. In steroid non-responders, other immunomodulatory therapies could be applied. Recently, Rituximab is reported as a safe and effective treatment for Hashimoto¡¯s encephalopathy. We report a 50-year-old woman with Hashimoto¡¯s encephalopathy presented with confusion and catatonia who was refractory to corticosteroid and immunoglobulin but effectively treated with rituximab.
KEYWORD
Encephalopathy, Thyroid hormones, Rituximab, Glucocorticoids
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø